Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.24.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets

 

    2023     2022  
    December 31,  
    2023     2022  
Deferred tax assets:                
Net operating loss carryforwards – Federal and state   $ 17,943     $ 14,614  
Net operating loss carryforwards – Israel     18,740       18,813  
Share-based compensation     975       1,735  
Capitalized research and development     2,184       1,698  
Accrued liabilities and reserves     409       681  
Total deferred tax assets     40,251       37,541  
Deferred tax liabilities:                
Right of use asset     (52 )     (109 )
Other     (39 )     (34 )
Total deferred tax liabilities     (91 )     (143 )
Net deferred tax assets before valuation allowance     40,160     37,398
Valuation allowance     (40,160 )     (37,398 )
Net deferred tax assets after valuation allowance   $ -   $ -
Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the federal statutory tax rate and the effective tax rates for the years ended December 31, 2023 and 2022 is as follows:

 

    2023     2022  
    For the Year Ended December 31,  
    2023     2022  
U.S. federal statutory tax rate     21.0 %     21.0 %
State income taxes, net of federal benefit     0.7       6.6  
U.S. vs. foreign tax rate differential     0.8       0.8  
Non-deductible expenses     (5.8 )     (2.7 )
Tax credits     1.9       -  
Deferred tax asset adjustments     (8.0 )     (10.7 )
Change in valuation allowance     (10.6 )     (15.0 )
Effective tax rate     - %     - %
Schedule of Reconciliation of NOL

A reconciliation of the Company’s NOLs for the years ended December 31, 2023 and 2022 is as follows:

 

    2023     2022  
    December 31,  
    2023     2022  
U.S. Federal NOL’s   $ 35,676     $ 26,875  
U.S. State NOL’s     34,266       25,464  
Israel NOL’s     81,480       81,794  
Total NOL’s   $ 151,422     $ 134,133